DMK Pharmaceuticals OverviewDMK Pharmaceuticals Research & Development
Research & Development expenses for DMK.
Quarterly R&D Expenses
$859846.00
↓ 59.97% YoY
As of Dec 31, 2022
Annual R&D Expenses (TTM)
$10.38M
↓ 7.84% YoY
Trailing 12 months ending Dec 31, 2022